B2B

Information on our contract manufacturing services and procurement processes.

GSK reserves the right to propose contractual terms and conditions that it considers appropriate to a particular procurement initiative. To speed up the contracting process and reduce the volume of paper when issuing purchase orders from certain sites around the world, GSK has developed some simple web-based sets of terms and conditions ("the General Terms & Conditions").

13%

estimated return of R&D investment

Rather than issue the General Terms & Conditions with each purchase order ("Order") issued, GSK incorporates them in each Order via a statement on each Order referring to this page.

Accessing the General Terms & Conditions

The following General Terms & Conditions and other supporting documents are applicable to orders issued by GSK sites or businesses based in the locations indicated below.

112.2p

Core earnings per share

You may need to install Adobe Reader to view these documents. If you are having difficulty viewing them, please call the telephone number set out in the relevant order.

These pages provide information and data taken from the GlaxoSmithKline plc (GSK) Annual Report 2013. They do not constitute the official version of the GSK Annual Report 2013 taken as a whole and do not contain sufficient information to allow a full understanding of the results and the state of affairs of GSK. Under no circumstances should the content of these pages be relied upon or used as the basis on which to make voting or investment decisions without prior consultation of the full GSK Annual Report 2013 and other more complete or up-to-date sources of information.

We want to eradicate malaria by 2020

Andrew Witty

Stock exchange and symbols

GlaxoSmithKline is quoted on the London and New York stock exchanges.

The company’s shares are listed on the New York Stock Exchange in the form of American Depositary Shares (ADSs) and these are evidenced by American Depositary Receipts (ADRs), each one of which represents two ordinary shares.

A critical link in combating neglected tropical diseases

Transcript

This section contains a collection of useful tools to enable investors to analyse current and historical GlaxoSmithKline share prices on the London and New York stock exchanges.

Detailed share price charting tool

This is a very pleasant picture

The tool contains detailed information about GlaxoSmithKline's share price including an interactive chart and share price download tool. Use the tabs at the top of each page to navigate between the London [GBP] and New York [USD] version of each tool.

Disclaimer for share price feed

The past performance of the price of securities must not be relied on as a guide to their future performance.

GlaxoSmithKline has not reviewed, is not responsible for, and accepts no liability in respect of, any information or opinion contained on any other website.

GlaxoSmithKline has not reviewed, is not responsible for, and accepts no liability in respect of, any information or opinion contained on any other website.

The money shot
For the media

GlaxoSmithKline has not reviewed, is not responsible for, and accepts no liability in respect of, any information or opinion contained on any other website.

GlaxoSmithKline has not reviewed, is not responsible for, and accepts no liability in respect of, any information or opinion contained on any other website.

These pages provide information and data taken from the GlaxoSmithKline plc (GSK) Annual Report 2013. They do not constitute the official version of the GSK Annual Report 2013 taken as a whole and do not contain sufficient information to allow a full understanding of the results and the state of affairs of GSK. Under no circumstances should the content of these pages be relied upon or used as the basis on which to make voting or investment decisions without prior consultation of the full GSK Annual Report 2013 and other more complete or up-to-date sources of information.